JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akhteruzzaman, S.
Right arrow Articles by Sugiyama, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akhteruzzaman, S.
Right arrow Articles by Sugiyama, Y.

Vol. 290, Issue 3, 1107-1115, September 1999

Carrier-Mediated Hepatic Uptake of Peptidic Endothelin Antagonists in Rats1

Sharif Akhteruzzaman, Yukio Kato, Hirokazu Kouzuki, Hiroshi Suzuki, Akihiro Hisaka, Bruno Stieger, Peter J. Meier and Yuichi Sugiyama

Graduate School of Pharmaceutical Sciences, University of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan (S.A., Y.K., H.K., H.S., Y.S.); Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd., Okubo, Tsukuba, Japan (A.H.); and Department of Medicine, Division of Clinical Pharmacology and Toxicology, University Hospital, Zurich, Switzerland (B.S., P.M.)

The endothelin antagonist BQ-123, an anionic cyclopentapeptide, is taken up by rat hepatocytes through active transport systems. Here, we have examined the hepatocellular uptake mechanism for several BQ-123 derivatives with anionic charges using isolated rat hepatocytes. BQ-485, a linear peptide, BQ-518, a cyclic peptide, and compound A, a cyclic peptide with a cationic moiety, were taken up by hepatocytes in a concentration-dependent manner. The uptake of BQ-485 was most efficient, whereas compound A showed comparable uptake with BQ-123. The uptake of these peptides was Na+- and energy-dependent, suggesting that active transport mechanisms are involved in their uptake into hepatocytes. BQ-485, BQ-518, and compound A can almost completely inhibit both the Na+-dependent and -independent uptake of [3H]BQ-123, with inhibition constants (Ki) that are comparable to the Michaelis-Menten constants (Km) for their Na+-dependent and -independent uptake, respectively. Inhibition by BQ-485 was competitive, and the uptake of BQ-485 can be inhibited by BQ-123, with Ki values that are comparable with the Km values for BQ-123 uptake. The uptake of BQ-123 by COS-7 cells transfected with either Na+-dependent taurocholate-cotransporting polypeptide (Ntcp) or Na+-independent basolateral organic anion-transporting polypeptide (oatp1) was minimal. Thus, these three peptides share the transporters that also recognize BQ-123 but appear to differ from Ntcp and oatp1.


0022-3565/99/2903-1107$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
R. Nakagomi-Hagihara, D. Nakai, K. Kawai, Y. Yoshigae, T. Tokui, T. Abe, and T. Ikeda
OATP1B1, OATP1B3, AND MRP2 ARE INVOLVED IN HEPATOBILIARY TRANSPORT OF OLMESARTAN, A NOVEL ANGIOTENSIN II BLOCKER
Drug Metab. Dispos., May 1, 2006; 34(5): 862 - 869.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. Nasu, Y. Kumagai, H. Kogetsu, M. Tsujimoto, H. Ohtani, and Y. Sawada
PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL FOR PRALMORELIN HYDROCHLORIDE IN RATS
Drug Metab. Dispos., October 1, 2005; 33(10): 1488 - 1494.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. Houle, J. Raoul, J.-F. Levesque, K. S. Pang, D. A. Nicoll-Griffith, and J. M. Silva
Retention of Transporter Activities in Cryopreserved, Isolated Rat Hepatocytes
Drug Metab. Dispos., April 1, 2003; 31(4): 447 - 451.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Kouzuki, H. Suzuki, B. Stieger, P. J. Meier, and Y. Sugiyama
Characterization of the Transport Properties of Organic Anion Transporting Polypeptide 1 (oatp1) and Na+/Taurocholate Cotransporting Polypeptide (Ntcp): Comparative Studies on the Inhibitory Effect of their Possible Substrates in Hepatocytes and cDNA-Transfected COS-7 Cells
J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 505 - 511.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.